Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 8 | 40 | 8 |
| Receivables | 130 | 30 | 20 |
| Inventories | 70 | 60 | 30 |
| Other current assets | 52 | 10 | 12 |
| TOTAL | $260 | $140 | $70 |
| Non-Current Assets | |||
| PPE Net | 370 | 330 | 380 |
| Other Non-Current Assets | 210 | 8 | 4 |
| TOTAL | $580 | $338 | $384 |
| Total Assets | $860 | $480 | $460 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 10 | 9 | 8 |
| Accounts payable and accrued liabilities | 40 | 20 | 150 |
| TOTAL | $70 | $30 | $180 |
| Non-Current Liabilities | |||
| Long Term Debt | 160 | 150 | 160 |
| Other Non-Current Liabilities | 50 | 100 | 90 |
| TOTAL | $210 | $250 | $250 |
| Total Liabilities | $290 | $290 | $430 |
| Shareholders' Equity | |||
| Common Shares | 1 | 0 | 0 |
| Retained earnings | -1,460 | -1,750 | -1,920 |
| Other shareholders' equity | -1 | -10 | 0 |
| TOTAL | $560 | $190 | $30 |
| Total Liabilities And Equity | $850 | $480 | $460 |